University Of Michigan Nephrology Clinic Anemia Management Orders Page 2

ADVERTISEMENT

11. cont every 4-5 week evaluation with adjustments as above until Hgb rise ≤ 1 g/dL/month and Hgb is
within target range; then cont every 4-5 week evaluation with adjustments as needed to maintain Hgb
in target range. If:
Hgb ≤9, notify MD
Hgb ≥9 and < 11, increase current dose by 1 step (~ 25%)
Hgb 11-12.5, maintain therapy
Hgb ≥12.5 and ≤13, decrease dose by 1 step (~ 25%)
Hgb >13, notify M.D. and ask M.D. whether to hold or administer;
if administered, M.D. must complete and sign justification for billing.
Increase dosing interval
12. Patients administering epo analog at home, should report blood pressures
13. Hold Erythropoietin if
Hgb >13
BP>190/110 (notify M.D.)
Adverse drug reaction (notify M.D.)
Other_________
14. See chart for stepwise Erythropoietin dose adjustments/conversions between Epotein alfa (Procrit)
and Darbopoetin alfa (Aranesp)
15. Iron Therapy
M.D. to manage iron therapy as necessary
Iron 325 mg po ___daily____twice daily____three times daily; call M.D. if TSAT < 20% and not
increased after 2 months iron therapy
Iron as above and give venofer as per protocol if TSATS <20% and do not increase after 2 months
iron po supplementation
Physician Signature _________________________ Date:_______________________
R.N. Signature _____________________________Date:_______________________
M.A. Signature ____________________________ Date:______________________
(if patient will be receiving injections at University of Michigan Nephrology Clinic)

ADVERTISEMENT

00 votes

Related Articles

Related forms

Related Categories

Parent category: Medical
Go
Page of 4